NCT05786456Active, not recruiting
e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study
Novel e-Health Intervention for Fear of Progression in Women With Gynecologic Cancer: A Pilot Study
Source: ClinicalTrials.gov · Last updated 4 Nov 2026
Brief summary (registry, in English)
This clinical trial studies how well an electronic (e)-health intervention (day-by-day) woks in managing fears or worries about cancer growing, spreading, or getting worse (progression) in patients with stage III or IV gynecologic cancer. Fear and worries about cancer progression or recurrence (coming back) are common concerns. This may contribute to concerns related to illness, worries, and uncertainty about the future. Day by Day is adapted from a program called "Conquer Fear" which was shown to benefit patients with early-stage cancer. Day-by-day intervention may help refocus patient thoughts and help patients learn skills to manage anxiety and fears.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 23 (actual)
- First submitted
- 10 Mar 2023
- Start date
- 19 Jul 2024
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- City of Hope Medical Center
- Diseases
- Cervical cancer, Ovarian cancer
- NCT number
- NCT05786456
What you commit to
- Study type: Interventional
- Participants enrolled: 23
- From 19 Jul 2024 to the primary completion date, 1 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Enrolled in hospice
- Severe depression as assessed by Patient Health Questionnaire (PHQ-9)
- Non-English speaking
- Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)
Who the study is looking for
- Women with stage III or IV GYN cancer (ovarian, endometrial, cervical, vulvar/vaginal);at least 3 months from initial diagnosis
- Age: \>= 18 years
- Score \>= 34 on the Fear of Progression Short-Form, indicating dysfunctional levels
- Ability to read and understand English
- Patients in remission or with progressive disease are eligible
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| City of Hope Medical Center Coordinator of this site? Confirm its status | Duarte | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.